The Reward and Employment Tax practice have extensive experience helping companies to prepare for the upcoming changes, share market practices, and tips as the deadline approached. 

Biosimilar new entry was expected to shake up the pharmaceuticals market, leading to lower prices and increased access to drugs. However, market access has been slower than many predicted, with some citing concerns around anti-competitive practices limiting entry and expansion.

In healthcare and life sciences, this April, we will reflect on the 15th anniversary of the first biosimilar to be approved in Europe.

We are aware of an increase in the number of enquiries into the tax treatment of carried interests HMRC are raising at a House level, as well as at an individual level. These enquiries are typically aimed at several investment management professionals, and we expect this scrutiny to grow in light of the Budget.

A&M’s latest insight article “The three components of a perfect data breach”, brings together the key learnings from the webinar, outlining details of a robust response and how, when done effectively, it can help companies preserve critical data and intellectual property while safeguarding brand reputation.

An insightful look at two recent tax court decisions and the key technical issues raised in the cases.

The Executive Compensation Services practice Managing Director, David Tuch and Director, Samantha Lenox discussed key issues Company Secretaries need to consider and implement when making grants under executive share plans.

After a tumultuous year for the global economy, transfer pricing models are likely to be impacted going forward.

Alvarez & Marsal’s Scotland office hosted their Scotland Asset Manager Breakfast briefing on Wednesday 10 March 2021.

The COVID-19 pandemic has placed increasing pressure on companies to protect their employees and the volume of employee claims around safety violations and negligence are growing.

The IRS is considering unexpected consequences that could arise in computing the business interest deduction limits upon the sale or disposition of stock of a consolidated group member with depreciable property.

Recently, the Tax Court has ruled or issued orders in three unique cases that could significantly impact the future of R&D tax credit claims. It is critical to understand what these rulings mean, how they impact your current and future claims, and their impact on ongoing audits and appeals.

In challenging financial and operational times, parties need more creative tools than ever before to reach settlement and bring swift resolution before issues can become protracted litigation. In this edition of Raising the Bar, A&M Managing Director Christy McLean takes us through the fundamentals of a Value Assurance Program and other solutions, how such programs offer advantages over traditional settlement structures and best practices for reaching the most successful outcomes.

Done right, IT Cost Optimization programs provide tactical short-term results and long-term benefits – sustainable and transformational change.